Fluid overload is an independent risk factor for acute kidney injury in critically Ill patients: results of a cohort study by unknown
RESEARCH ARTICLE Open Access
Fluid overload is an independent risk factor
for acute kidney injury in critically Ill
patients: results of a cohort study
Nawal Salahuddin1* , Mustafa Sammani1, Ammar Hamdan1, Mini Joseph2, Yasir Al-Nemary3, Rawan Alquaiz1,
Ranim Dahli1 and Khalid Maghrabi1
Abstract
Background: Acute Kidney injury (AKI) is common and increases mortality in the intensive care unit (ICU). We
carried out this study to explore whether fluid overload is an independent risk factor for AKI.
Methods: Single-center prospective, observational study. Consecutively admitted, ICU patients were followed for
development of AKI. Intravenous fluid volumes, daily fluid balances were measured, hourly urine volumes, daily
creatinine levels were recorded.
Results: Three hundred thirty nine patients were included; AKI developed in 141 (41.6%) patients; RISK in 27 (8%)
patients; INJURY in 25 (7%); FAILURE in 89 (26%) by the RIFLE criteria. Fluid balance was significantly higher in
patients with AKI; 1755 ± 2189 v/s 924 ± 1846 ml, p < 0.001 on ICU day 1. On multivariate regression analysis, a net
fluid balance in first 24 h of ICU admission, OR 1.02 (95% CI 1.01,1.03 p = 0.003), percentage of fluid accumulation
adjusted for body weight OR1.009 (95% CI 1.001,1.017, p = 0.02), fluid balance in first 24 h of ICU admission with
serum creatinine adjusted for fluid balance, OR 1.024 (95% CI 1.012,1,035, p = 0.005), Age, OR 1.02 95% CI 1.01,1.03,
p < 0.001, CHF, OR 3.1 (95% CI 1.16,8.32, p = 0.023), vasopressor requirement on ICU day one, OR 1.9 (95% CI 1.13,3.
19, p = 0.014) and Colistin OR 2.3 (95% CI 1.3, 4.02, p < 0.001) were significant predictors of AKI. There was no
significant association between fluid type; Chloride-liberal, Chloride-restrictive, and AKI.
Conclusions: Fluid overload is an independent risk factor for AKI.
Keywords: Acute kidney injury, Fluid overload, Renal congestion, Chloride-liberal fluids, Critical illness
Background
Acute Kidney injury (AKI) develops in 55–66% of critic-
ally ill patients [1, 2] with an attributable mortality of
15–80%, dependent on the severity of renal dysfunction
[3, 4]. The ICU physician has no influence over the usu-
ally described AKI risk factors; severity of illness,
hemodynamic instability, comorbid illnesses, heart fail-
ure, cirrhosis and emergency surgery [2, 5–7], however
if potentially modifiable factors can be identified there is
a real potential to reduce either the incidence or the se-
verity of any renal injury.
Fluid overload is related to an increase in overall mor-
tality with critical illness [8, 9]. In patients with estab-
lished AKI, further fluid overloading has been linked
with lower survival and lesser renal recovery [10–14].
There is emerging evidence that suggest a role for
fluid overlcoad as a causative factor for AKI [15, 16]. It
is biologically plausible that volume loading leads to
organ congestion and a resultant decrease in renal blood
flow [17, 18]. Whether fluid overload leads to cellular
dysfunction from reduced perfusion, tissue hypoxia or
by direct disruptions in cellular function is still not clear.
Interestingly the renal capsule itself may cause a ‘com-
partment syndrome’ by its inability to distend when
renal congestion occurs. Previous investigators have
shown that a capsule ‘ectomy’ improves renal blood flow
[19]. An additional risk factor for AKI appears to be
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chloride—liberal intravenous fluids that contain ‘supra-
physiological’ concentrations of chloride, such as 0.9%
saline, a routine intravenous solution in most intensive
care units (ICUs) [20–22]. Recent work has linked chlor-
ide—liberal intravenous solutions with AKI [23, 24].
The objectives of this study were to determine
whether the potentially modifiable risk factors of
Fluid overload and Fluid Type (chloride—liberal ver-
sus chloride—restrictive) are risk factors for AKI in
critically ill patients. We hypothesized that patients
admitted to the ICU may be at a higher risk of AKI
if they had a net positive fluid balance or received
chloride—liberal fluids for both resuscitation and as
maintenance therapy.
Methods
This study is reported following the STROBE statement
checklist for observational studies [25].
Study design and setting
This was a prospective, cohort study carried out on con-
secutive, critically ill, adults admitted to Medical and
Surgical ICUs at a tertiary care, referral hospital over a
5-month period between 8/2013 and 12/2013.
Operational definitions
Acute Kidney Injury (AKI) was defined according to the
RIFLE Classification [26] of renal dysfunction and catego-
rized into RISK, INJURY and FAILURE. Renal dysfunction
was defined using both increases in creatinine from
admission values and urine output measured as urine vol-
ume in milliliters/patient’s baseline weight in kilograms/h;
as weights are routinely measured on admission for all
ICU admissions, Serum creatinine values were measured
at admission and daily for up to the seventh ICU day.
Serum creatinine from the patients’ outpatient records
provided a baseline creatinine value and values were avail-
able for all patients. Serum creatinine was measured using
the COBAS Integra Creatinine plus ver. 2 Assay, Roche
Diagnostics Corporation. This is an enzymatic method
based on the determination of hydrogen peroxide after
conversion of creatinine with the aid of creatininase, crea-
tinase, and sarcosine oxidase. Patients were screened for
the development of post-admission AKI on a daily basis.
Pre-Existing Renal Impairment was defined as elevated
serum creatinine in the pre-ICU admission medical re-
cords, i.e: abnormal baseline creatinine. Fluid Overload
was defined as a net positive fluid balance. Additionally
we computed the percentage of fluid accumulation ad-
justed for body weight by using the formula; Total intake
(liters) – Total output (liters)/baseline body weight and
expressed as a percentage [27]. Intravenous fluids were
classified into ‘Chloride-liberal’ fluids, i.e.: those containing
supraphysiological concentrations of chloride (0.9% saline,
20 and 5% albumin) and ‘Chloride-restrictive’, which con-
tain chloride concentrations closer to plasma (0.45% sa-
line, Ringer’s lactate).
Participants
Consecutive, critically ill adults admitted within the
pre-specified study period were included. Routine, post-
operative patients admitted for less than 72 h, patients
with AKI at ICU admission and end-stage renal disease
patients treated by chronic dialysis were excluded. Crys-
talloids used in the study patients were; Lactated Ringers
(sodium chloride, potassium chloride, sodium lactate
and calcium chloride) injection, 0.9% Sodium Chloride
Injection, USP, 0.45% Sodium Chloride Injection, USP.;
manufactured by Baxter,Baxter Healthcare Corporation,
DeerfieldIL60015 USA. Colloids used were; Human
Albumin 5 and 20% manufactured by Biotest Pharma
GmbH, Landsteinerstraße 5, 63303 Dreieich, Germany.
Variables
The primary outcome variable was the development of
AKI as defined above. Other recorded variables were,
24-h fluid balance, types of intravenous fluids received
during the ICU stay, comorbidities, demographics (age,
gender, operative status), severity of Illness scores
(APACHE II [28],SAPS II [29]), routine hematological,
biochemical and organ dysfunction/physiological (vaso-
pressors, renal replacement therapy (RRT), mechanical
ventilation) data, usage of potentially nephrotoxic
medications such as NSAIDs, iodinated contrast, intra-
venous starch, vancomycin, Colistin.
Statistical analysis
Continuous data was tested for normality; measures of
central tendency were compared as means ± standard
deviations (SD) using the Student t test for normally dis-
tributed variables and as medians (interquartile range,
IQR) using the Mann–Whitney U test for skewed data.
Categorical variables were compared using the CHI2 test
or the Fisher Exact test for n < 5. Fluid volumes were
dealt with as continuous variables whilst fluid types
were classified into either ‘Chloride-liberal’ or ‘Chloride-
restrictive’ and correspondingly dealt with as continuous
variables. Logistic regression analysis was performed to
determine the predictive ability of variables for AKI.
Univariate and multivariate techniques were used, and
for multivariate regression, a backward mode with a
threshold 0.10 was used for elimination. Multivariate as-
sociations were reported as odds ratios (OR) with 95%
confidence intervals. A sensitivity analysis was carried
out with the serum creatinine adjusted by fluid balance,
using the formula;
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Adjusted Serum Creatinine
¼ Serum Creatinine x correction factor
when correction factor = 1 + {cumulative fluid balance
(L)/(admission body weight (kg) × 0.6)} [30]. A two-sided
p value of < 0.05 was considered as statistically significant.
All analyses were carried out using IBM SPSS version 22.0.
Results
Participants and descriptive data
Three hundred and thirty-nine patients were included;
AKI developed in 141 (41.6%). Mean time to develop-
ment of AKI was 1.9 ± 0.4 days (range 1,3). Mean age
was 51 ± 20.4 years, 167 (49%) patients were male. Mean
APACHE II score was 22 ± 12.8 and SAPS II score was
35.4 ± 18.9. Severe sepsis/septic shock was the admitting
diagnosis in 129 (38%) patients, 56 (16.5%) were admitted
with respiratory failure and 60 (18%) patients were post-
operative.
Comorbid conditions included; malignancy 149 (44%),
diabetes mellitus 110 (32%), chronic liver disease 81(24%),
connective tissue disease 81 (24%) and congestive heart
failure (CHF) 23(7%). During ICU admission, patients re-
ceived vancomycin, 223 (66%), Colistin 97 (29%), amino-
glycosides 57 (17%), NSAIDs 0 (0%), iodinated contrast 73
(21.5%). Thirty- three (10%) patients had pre-existing
renal impairment. Net fluid balance at 24 h of ICU admis-
sion was +1027 ml (IQR 25% 0, 75%, +1710). Loop and
thiazide diuretics were used in 238 (70%) patients (Fig. 1).
In patients who developed AKI, mean arterial pres-
sures were significantly lower; 66.8 ± 18.6 v/s 71 ± 13.7,
p = 0.015 on Day 0 and 67.8 ± 18 v/s 73.5 ± 16, p = 0.002
on Day 3, with significantly higher serum lactate levels,
2.7 ± 1.9 v/s 2.0 ± 2.6, p = 0.02. No significant differences
were found in lactic acid clearance; serum lactate at 6 h
1.6 (2) v/s 1.9 (2), p value NS or central venous oxygen
saturation (ScvO2); 68.5 ± 24.8 v/s 71.5 ± 22.6, p value
NS at admission and 67 ± 25.4 v/s 65.7 ± 25, p NS at
24 h. Fluid balance was significantly higher in patients
with AKI; 1755 ± 2189 v/s 924 ± 1846 ml, p < 0.001 on
ICU day 1 and 665 ± 1686 v/s 167 ± 1658 ml,
p = 0.007 on day 3 (Fig. 2). There was no significant
differences found in the volumes of fluid types re-
ceived for both resuscitation or for maintenance;
Chloride-Liberal fluids in first 24 h 4880 ml (IQR
3342) v/s 5500 (IQR 4729), p 0.20, Chloride-
Restrictive fluids in first 24 h 3665 (2000) v/s 2610
(IQR 2000), p 0.22, Chloride-Liberal fluids in first
48 h 1079 (IQR 894) v/s 970 (IQR 838), p 0.33 and
Chloride-Restrictive fluids in first 48 h 1949 (IQR
650) v/s 1983 (IQR 763), p 0.32.
Serum chloride values also were not different between
the AKI and non-AKI group throughout the ICU stay,
112 ± 21 v/s 108 ± 28 mmol/L, p = 0.22 (Table 1).
Outcomes
AKI developed in 141 (41.6%) patients; RISK in 27 (8%)
patients; INJURY in 25 (7%); FAILURE in 89 (26%) by
the RIFLE classification and using both creatinine and
urine output criteria; AKI defined only by increase in
serum creatinine developed in 64 (19%), whilst AKI by
urine output criteria developed in 130 (38.3%). When
serum creatinine was adjusted for fluid balance, AKI was
diagnosed in 153 (45%) patients (Fig. 3).
Fig. 1 Causes of ICU admission
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Ninety-three (27%) patients were started on continu-
ous renal replacement therapy (CRRT). Mean ICU
length of stay was 9.3 ± 11.3 days. ICU survival was 86%
(292 patients), 28-day survival 80% (270 patients).
Univariate outcome data
On univariate regression analysis; development of AKI
was significantly associated with net fluid balance on the
first ICU admission day, OR 1.2 (95% CI 1.1,1.3, p < 0.001);
percentage of fluid accumulation adjusted for body weight
OR1.01 (95% CI 1.004,1.018, p = 0.002); net fluid balance
on the 3rd ICU admission day OR 1.02, 95% CI 1.01,1.03,
p = 0.027; age, OR 1.02 (95% CI 1.01,1.03, p < 0.001); CHF,
OR 3.1 (95% CI 1.2,7.9, p = 0.013); APACHE II scores, OR
1.02 (95% CI 1.0,1.04, p = 0.01); SAPS II scores, OR 1.02
(95% CI 1.007,1.03, p = 0.002); Admission MAP OR 0.98
(95% CI 0.96,0.99, p = 0.008); Vasopressors at admission,
OR 2.5 (95% CI 1.5,4.0, p < 0.001) and for greater than
24 h, OR 2.37 (95% CI 1.48, 3.7, p < 0.001); admission lac-
tate OR 1.17, 95% CI 1.03.1.33, p = 0.014 and Colistin, OR
2.52 (95% CI 1.52,4.18, p < 0.001). Fluid balance remained
a significant predictor of AKI as defined by urine output
only, OR 1.01 (95% CI 1.007,1.02, p = 0.002 and by creatin-
ine only, OR 1.012 (95% CI 1.008,1.016, p = 0.013) and by
serum creatinine adjusted for fluid balance OR 1.02
(95% CI 1.01,1.03, p < 0.001). There was no significant
association between fluid types and AKI; Chloride-
liberal, p = 0.20 and Chloride-restrictive, p = 0.22, serum
chloride and AKI, p = 0.46 or ICU, p = 0.14 and 28-day
mortalities, p = 0.81.
Multivariate analysis
After adjusting for covariates, a net fluid balance in first
24 h of ICU admission, OR 1.02 (95% CI 1.01,1.03
p = 0.003), percentage of fluid accumulation adjusted
for body weight OR1.009 (95% CI 1.001,1.017, p = 0.02),
fluid balance in first 24 h of ICU admission with serum
creatinine adjusted for fluid balance, OR 1.024 (95% CI
1.012,1,035, p = 0.005), Age, OR 1.02 95% CI 1.01,1.03,
p < 0.001, CHF, OR 3.1 (95% CI 1.16,8.32, p = 0.023), vaso-
pressor requirement on ICU day one, OR 1.9 (95% CI
1.13,3.19, p = 0.014) and Colistin OR 2.3 (95% CI 1.3, 4.02,
p < 0.001) remained significant predictors of AKI (Table 2).
Discussion
The main findings of this study are that a positive fluid
balance in the first 24 h of ICU admission is associated
with a significant risk of AKI in a mixed critically ill
population. We were not able to determine an associ-
ation between types of intravenous fluids and AKI.
Fluid overload that occurs either with resuscitation or
with indiscriminate use is now becoming recognized as
a risk factor in itself for ICU complications. In 2011, Liu
et al. [15] published a posthoc analysis of the Fluid and
Catheter Treatment Trial (FACTT) data where they de-
scribed a higher incidence of AKI after adjustment for
fluid balance in patients allocated to the fluid liberal
group (66% v/s 58%, p = 0.007). Hassinger et al. [16] in
an observational study of 98 pediatric post-cardiac sur-
gery patients described greater risk of AKI with postop-
erative fluid overload (described as a fluid balance 5%
above body weight). Cumulative fluid administered was
an excellent predictor of pediatric-modified Risk, Injury,
Failure, Loss and Endstage (AUC 0.963, 95% CI 0.91-1.0,
P = 0.002). Wang et al in the recently published Beijing
Acute Kidney Injury Trial [27] conducted in 30 ICUs
and that included 1172 patients with AKI, showed that
fluid overload was an independent risk factor for the
Fig. 2 Comparison of Fluid balances in patients with and without AKI. Significant differences between fluid balance at 24 h of ICU admission,
p < 0.001 and at 72 h, p = 0.007
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incidence of AKI (odds ratio 4.508, 95% confidence
interval 2.900 to 7.008, p < 0.001) and for increased se-
verity of AKI. AKI patients who died had a higher cumu-
lative fluid balance during the first 3 days (2.77 [0.86–
5.01] L versus 0.93 [−0.80 to 2.93] L, p < 0.001) com-
pared to survivors.
Fluid overload is postulated to cause renal dysfunction
in a number of ways. Renal congestion and interstitial
edema lead to distortion of the renal architecture and
impaired metabolite diffusion, compromised tissue oxy-
genation. Capillary and lymphatic obstruction ensues
with further organ congestion [17, 18]. The renal capsule
limits the kidney’s ability to accommodate increasing
hydrostatic interstitial pressures and eventually leads to
reduce renal perfusion and glomerular filtration. Decap-
sulation, in an animal model of resuscitation, has been
described to protect the kidney from injury Increased
intra-abdominal pressures from fluid loading comprom-
ise renal blood flow and contribute further to fluid over-
load by reduced salt and water excretion [19].
An association between fluid overload and renal dys-
function however does not prove causality. It is possible
Table 1 Comparison of variables in critically ill patients with and
without Acute Kidney Injury





Age 56 ± 19 47 ± 20.5 <0.001
Male 76 (51%) 91 (48%) 0.57
APACHE II 25 ± 12 21 ± 13.5 0.006
SAPS II 42 ± 20 30 ± 16 <0.001
Post-operative 40 (27%) 68 (35.6%) 0.09
CHF 16 (11%) 7 (4%) 0.009
Diabetes 52 (35%) 58 (30%) 0.54
COPD 5 6 0.93
Malignancy 65 84 0.86
Cirrhosis 39 42 0.44
Renal Impairment prior to
ICU admission
15 18 0.91
Connective Tissue Disease 36 45 0.85
Cause of ICU Admission 0.31
Severe Sepsis/Septic Shock 55 73
Postoperative Complications 24 36
Respiratory Failure 20 36
Acute Neurologic event 12 19
Heart Failure/Arrhythmia 17 11
Othersa 15 21
Vancomycin 106 (72%) 117 (61%) 0.046
Colistin 48 (32%) 49 (26%) 0.10
Aminoglycosides 22 (15%) 35 (18%) 0.29
Serum Creatinine (mmol/L)
at admission 145 ± 116 86.5 ± 168 <0.001
Day 1 153.6 ± 117 75.6 ± 17 < 0.001
Day 2 148.4 ± 107 73.1 ± 7 < 0.001
Day 3 147.3 ± 101 69.2 ± 6 < 0.001
Urine output (ml/kg/hour)
Day 1 0.62 ± 0.6 1.36 ± 0.9 < 0.001
Day 2 0.74 ± 0.8 1.49 ± 0.7 < 0.001
Day 3 0.71 ± 0.8 1.43 ± 1 < 0.001
MAP (mmHg) mean (SD)
Day 0 66 ± 16 71 ± 14 0.033
Day 1 68.6 ± 13.3 70.7 ± 11.8 0.12
Day 2 69.2 ± 15.8 71.4 ± 15 0.20
Day 3 67 ± 18 74 ± 15 0.002
Patients on Vasopressors
Day 1 76 62 <0.001
Day 2 77 65 0.001
Day 3 71 58 0.001
Table 1 Comparison of variables in critically ill patients with and
without Acute Kidney Injury (Continued)
Serum Lactate (mmol/L)
at admission 2.7 ± 1.9 2.0 ± 2.6 0.02
at 6 h 1.6 (2) 1.9 (2) 0.91
ScvO2
at admission 68.5 ± 24.8 71.5 ± 22.6 0.86
at 24 h 67 ± 25.4 65.7 ± 25 0.66
Fluid Balance (ml) median(IQR)
Day 1 + 1500 (3254) + 869 (2284) 0.002
Day 2 + 744 (2292) + 486 (2250) 0.017
Day 3 + 518 (1521) 0 (1604) 0.043
Fluid Volume (ml) median(IQR)
Chloride-Liberal fluids in
1st 24 h
4880 (3342) 5500 (4729) 0.20
Chloride-Restrictive solutions
1st 24 h
3665 (2000) 2610 (2000) 0.22
Chloride-Liberal fluids by 48 h 1079 (894) 970 (838) 0.33
Chloride-Restrictive fluids
by 48 h
1949 (650) 1983 (763) 0.32
Serum Chloride (mmol/L)
at 24 h 111 ± 18.7 113 ± 17 0.69
at 48 h 113 ± 15.5 113 ± 15 0.17
ICU mortality 19 27 0.89
28 day Survival 114 159 0.74
aIncludes Venous thromboembolism, decompensated cirrhosis
Abbreviations: APACHE Acute Physiology Age Chronic Health Evaluation, SAPS
simplified acute physiology score, MAP mean arterial pressure, CHF congestive
heart failure
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that fluid overload represents an epi-phenomenon and is
a reflection of the severity of hypoperfusion and the
resuscitative response. Our findings are limited by our
observational design and the observed associations may
be subject to bias from selection, confounding or ran-
dom error. We attempted to control for confounders by
using regression analysis. Another limitation is the exter-
nal validity or generalizability of our results to other crit-
ically ill patients since we collected data only from a
single institution. Possible biases are also parameters
followed for fluid administration and blood transfusion.
Currently our ICU protocols attempt goal-directed fluid
resuscitation using inferior vena cava ultrasound mea-
surements to guide fluid administration. Blood transfu-
sion triggers are serum hemoglobin values < 7 mg/dl.
Since these are universally accepted parameters by most
ICU physicians, we believe that the fluid administration
and transfusion practices at our institution may cause
limited bias.
We did not find any association between the develop-
ment of AKI and whether predominantly chloride-liberal
or chloride-restrictive fluids were used for either initial
resuscitation or subsequent maintenance. These findings
are contrary to recent work published by Yunos et al.
[23], in a pre and post-intervention study on 1530 critic-
ally ill patients found that a chloride-restrictive fluid
strategy resulted in a significant reduction in AKI, need
for renal replacement therapy and increase in creatinine
as compared to a control group given chloride-liberal
fluids. Similarly we recently reported on a significant
association between AKI and larger volumes of chloride-
liberal (hyperchloremic) fluids in 158 post-liver trans-
plant patients [24]. In that study the AKI-group had
significantly higher serum chloride levels compared to
Fig. 3 Incidence of AKI as defined by RIFLE Classification; both creatinine and oliguric criteria, by creatinine only and oliguria only [26]
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transplant recipients that did not develop AKI. In our
current study with a cohort of mixed population of
critically ill patients, the mean serum chloride levels
throughout the ICU stay were not significantly different.
Therefore, it is possible that the AKI seen in patients re-
ceiving chloride-liberal fluids is due to chloride toxicity
and occurs when relative hyperchloremia develops.
Animal studies have demonstrated renal vasoconstric-
tion and thromboxane release after chloride infusions
[21] with chloride infusions increasing delivery to the
macula densa that stimulates glomerulotubular feedback
leading to afferent arteriole constriction, mesangial con-
traction and resultant decreases in GFR [22]. Clearly,
further work to establish a cutoff hyperchloremic value
can be considered.
In this study, we also found no significant association
between a diagnosis of sepsis and AKI; however, signifi-
cant associations with baseline mean arterial pressures
and vasopressor usage and AKI suggest that the renal im-
pact of sepsis maybe more a function of hemodynamic in-
stability. In addition, there was no mortality difference
between the AKI and non-AKI cohorts. Possibilities are
the beneficial impacts of early and adequate hemodynamic
resuscitation (as evidenced by the normalization of serum
lactate in both groups by 6 h or the mixed venous satur-
ation at admission) or the benefits of early renal replace-
ment therapy (CRRT was started in all RIFLE 3 within the
first 24 h).
Conclusions
In summary, large infusions of fluids may predict a
higher risk of AKI in critically ill patients. Our findings
support the hypothesis that ‘routine’ intravenous fluids
may not be routine and in themselves be associated with
organ dysfunction. Our results can be used to build hy-
potheses for further controlled trials.
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Table 2 Predictors of acute kidney injury by regression analysis
Variable Exp (B) 95% CI p value
Univariate analysis
Net fluid balance on the first
ICU admission day
1.2 1.1,1.3 <0.001
Net fluid balance on the 2nd
ICU admission day
1.02 1.01,1.03 0.11
Net fluid balance on the 3rd
ICU admission day
1.02 1.01,1.03 0.027
Percentage of fluid accumulation
adjusted for body weight
1.01 1.004,1.018 0.002
Age 1.02 1.01, 1.03 <0.001
CHF 3.1 1.2, 7.9 0.013
APACHE II scores 1.02 1.01, 1.04 0.011
SAPS II scores 1.02 1.007, 1.03 0.002
Admission MAP 0.98 0.96, 0.99 0.008
Vasopressors at admission 2.5 1.5, 4.0 <0.001
Vasopressors at 24 h 2.37 1.48, 3.7 <0.001
Admission serum lactate 1.17 1.03, 1.33 0.014
Colistin 2.52 1.52, 4.18 <0.001
Multivariate analysis
Net fluid balance on the first
ICU admission day
1.02 1.01,1.03 0.003
Percentage of fluid accumulation
adjusted for body weight
1.009 1.001,1.017 0.02
Vasopressors at 24 h 1.9 1.13,3.19 0.014
Age 1.02 1.01,1.03 0.001
Congestive Heart Failure 3.1 1.16,8.32 0.023
Colistin 2.3 1.3, 4.02 <0.001
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